Neoplasia/BPH

	Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-Analysis. Clin Genitourin Cancer Zhou S, Rao SRGG, Patel V, Kishi N, Benjamin S, Homsi J, Tsao CK. PMID: 42350220 [PubMed - as supplied by publisher]
	Contemporary Prostate Cancer Intraprostatic Imaging Scores: A Practical and Hands-on Guide for Urologists. Eur Urol Focus Nicoletti R, Chiu PKF, Giganti F, Eapen R, Kinnaird A, Simonato A, Pavan N. PMID: 42350200 [PubMed - as supplied by publisher]
	Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial. Eur Urol Yao Y, Liu Y, Li Y, Lu B, Lyu D, Cui X, Pan X. PMID: 42350167 [PubMed - as supplied by publisher]
	PRDX1 as a novel urinary biomarker for bladder cancer: Development of an integrated fiber optic sensing platform. Talanta Cheng K, Zhang HB, Xie HR, Wang L, Zhang T, Wan S, Yang JW, Hong PG, Wang XY, Jiao PP, Xu CH, Deng YD, Chen SY, Ding LY, Yang L. PMID: 42349259 [PubMed - as supplied by publisher]
	Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol Shore N, Nguyen, Kang B, Sawhney A, Byrne C, Tang J, Gorritz M, Chen CC, Patel J. PMID: 42350703 [PubMed - as supplied by publisher]
	A nationwide histopathology study reflecting the impact of the introduction of MRI in the diagnostic trajectory of prostate cancer in routine clinical care. Prostate Cancer Prostatic Dis Prinsen AMA, Slagter S, Schoots IG, van Leenders GJLH, van Melick HHE, Sedelaar JPM, Somford DM, van den Bergh RCN. PMID: 42350634 [PubMed - as supplied by publisher]
	Post-diagnosis physical activity in relation to mortality among prostate cancer survivors: a systematic review and meta-analysis. Cancer Causes Control Benker P, Hamann A, Leitzmann MF, Stein MJ. PMID: 42348026 [PubMed - indexed for MEDLINE]
	Association between dynamic abdominal obesity (DAO) and benign prostatic hyperplasia (lower urinary tract symptoms): evidence from the China Health and Retirement Longitudinal Study (CHARLS). World J Urol Liu H, Li B, Huang Y, Wang W, Cai J. PMID: 42347981 [PubMed - indexed for MEDLINE]
	Hospital caseload thresholds for improved perioperative outcomes during transurethral resection or enucleation of the prostate: results from the GRAND study. World J Urol Pyrgidis N, Schulz GB, Weinhold P, Volz Y, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P. PMID: 42347940 [PubMed - indexed for MEDLINE]
	Bladder drainage using the coreflow prostatic stent after REZUM therapy. World J Urol Long-Depaquit T, Sordelli F, Charvet AL, Agüero C, Secco S, Sarrazin C, Baboudjian M, Fourmarier M. PMID: 42347888 [PubMed - indexed for MEDLINE]
	Robotic Partial Nephrectomy: Different Surgical Approaches for Different Locations. Cancer Med Yu L, Zhao X, Duan P, Shu F, Liu Z, Zhang H, Zhang F, Yan Y, Zhang S. PMID: 42347742 [PubMed - indexed for MEDLINE]
	Diagnosis of Prostate Cancer: A Comparative Evaluation of Biological Techniques. Diseases Tshoni UA, Mbonane TP, Rathebe PC. PMID: 42346309 [PubMed]
	Mechanisms of Progression and Challenges for Intervention in the Natural History of Early Prostate Cancer: A Narrative Review. Curr Oncol Sandhu K, Pacey S, Brewer DS, Gnanapragasam VJ. PMID: 42346270 [PubMed - indexed for MEDLINE]
	Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance. Curr Oncol Speicher T, Demirkol IE, Blickle A, Bastian MB, Maus S, Schaefer-Schuler A, Bartholomä M, Burgard C, Ezziddin S, Rosar F. PMID: 42346249 [PubMed - indexed for MEDLINE]
	Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis. Curr Oncol Meagher MF, Birouty N, Musso G, Patil D, Saito K, Yasuda Y, Puri D, Baker B, Yuen K, Roberts JL, Ahdoot A, Baker O, Dabbas M, Cortes J, Fujii Y, Master V, Liss M, Derweesh IH. PMID: 42346227 [PubMed - indexed for MEDLINE]
	Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network. Curr Oncol Di Napoli M, Coppola E, D'Aniello C, Scagliarini S, Buonerba C, Muto A, Formisano L, Sabbatino F, Bosso D, Rossetti S, Lobianco L, Tambaro R, Di Costanzo F, Rescigno P, Pisano C, Cecere SC, Passarelli A, Ventriglia J, Calvanese G, Lamia MR, Perri E, Contieri R, Franzese D, Simeoni MA, Giorgio CM, Feroce F, Stilo S, Pacifico G, Canciello G, Pignata S. PMID: 42346225 [PubMed - indexed for MEDLINE]
	Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study. Curr Oncol Uccello M, Gee AL, Bennett JA, Hazell HL, Ruiz-Echarri Rueda M, Beresford MJ. PMID: 42346220 [PubMed - indexed for MEDLINE]
	Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review. Curr Oncol Portu M, Sanz-Beltran J, Duarte Borges MA, Navarro J, Arias A, Alvarez P, Fernández-Rebollo A, Reyes C, Flores J, Anguera G, Maroto P. PMID: 42346214 [PubMed - indexed for MEDLINE]
	Cancer Detection and Surveillance Pathways with Abbreviated MRI in the Prostate, Pancreas, and Liver: A Risk-Stratified Narrative Review. Curr Oncol Brown H, Clarke SE. PMID: 42346206 [PubMed - indexed for MEDLINE]
	Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group). Curr Oncol Tomioka-Inagawa R, Tomioka M, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T. PMID: 42346203 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188877

Page 1 of 9444



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy